SCILEX HOLDING CO sold 96.2% of their position (12.50M shares) of SEMNUR PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $200.00M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/25/2025ACC: 0001193125-25-218151
10% Owner
Since Sep 2025
-12.50M
Net shares
Net seller
$200.00M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
12.50M disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−11.95M
Price / share
$16.00
Trade value
$191.12M
% of position
6.2%
9/23/2025
193.75M→181.80M
Common Stock
Direct
Shares
−554.85K
Price / share
$16.00
Trade value
$8.88M
% of position
52.6%
9/23/2025
1.05M→500K
Total
Net shares
−12.50M
Net value
-$200M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/23/2025 | S · Sale | −11.95M | $16.00 | $191.12M | 6.2% | 193.75M | 181.80M |
| Common Stock Direct | 9/23/2025 | S · Sale | −554.85K | $16.00 | $8.88M | 52.6% | 1.05M | 500K |
| Total | −12.50M | -$200M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned6.25M
Total
6.25M indirect6.25M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.25M | Indirect |
| Total | 6.25M | 6.25M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported